Cuba can control a possible major epidemic caused by COVID-19 thanks to its health system and well-planned organization, Dr. Manuel Romero Placeres, director of the Pedro Kouri Institute of Tropical Medicine (IPK), said on Thursday.
Cuba extends scope of testing to COVID-19
Cuba has specialists to determine the peak moment of the COVID-19
Cuban medical brigade will fight COVID-19 in Angola
About 256 health specialists from Cuba, members of the Henry Reeve brigade, will arrive in Angola to combat the spread of the new SARS CoV-2 coronavirus, declared a pandemic last March 11 by the World Health Organization (WHO).
Cuban medical brigade Henry Reeve starts preparation in Suriname
The Cuban medical brigade Henry Reeve, which has been in Suriname since last Friday to combat the COVID-19, began its preparations in that country this Wednesday with a visit to the hospital that has been set up to deal with the new coronavirus.
Cuban medical brigades support to other nations does not affect services in the country
In view of the concern that due to the principles of internationalism and Cuba's support to other countries for the treatment of COVID-19, the nation's health services will be affected, the Ministry of Public Health (MINSAP by its Spanish acronym) assured this Wednesday that this does not affect the professionals or resources in the local fight.
Cuban medical brigade to Belize to fight COVID-19
In the fight against COVID-19, Cuba continues spreading solidarity in several nations of the world and a sign of this is that a Cuban medical brigade, made up of 25 cooperators, is travelling this Wednesday to Belize.
Cuba: Latest news on COVID-19: measures taken and thanks to Cuban solidarity
The application of measures in all the country's territories and the praise of Cuban medical collaboration, by Tedros Adhanom Ghebreyesus, director general of the World Health Organization (WHO), stand out among the most recent news on the new pandemic COVID-19.
Interferon Alpha 2B, among the most used to tackle COVID-19
The Recombinant Alpha Interferon 2B, a drug that Cuba produces and which is also made with Cuban technology in the Chang Heber joint venture, has a wide reach in the treatment of COVID-19 in China and other nations.
Cuba produces 22 medicines against Covid-19
A total of 22 drugs used in the confrontation and treatment of Covid-19, among which interferon alpha 2B is highlighted for its proven results in China, are produced in plants of the Biocubafarma business group.
Cuba confirms two new COVID-19 cases
Cuba confirmed two new positive cases of COVID-19 on Tuesday, totaling seven in the country, but it cannot be said there is transmission in the country nor is it urgent to establish a quarantine, Francisco Duran, national director of epidemiology at the health ministry said.
Cuban laboratories guarantee identification of COVID-19 suspects
The Molecular Microbiology laboratories in Villa Clara (central Cuba) and Santiago de Cuba (eastern of the country) are strongholds for determining potential patients infected with the new coronavirus.
Cuba with no potential risk to take extreme measures facing Covid-19
Cuba is still with four confirmed cases of COVID-19, tests were done on people who have had epidemiological risk and clinical manifestations consistent with the disease and have been negative, so no drastic measures such as closing schools or borders will be taken to date.
Cuban drug used to tackle COVID-19
Developed in 1986 by a team of researchers from the Center for Genetic Engineering and Biotechnology (CIGB), human recombinant Interferon Alfa 2B has benefited thousands of Cuban patients since its introduction into the national health system, and is one of the drugs currently used to combat the new coronavirus COVID-19.
FAO, Green Climate Fund and Cuban agriculture to launch first project
Representatives of the United Nations Food and Agriculture Organization (FAO) and the Green Climate Fund (GCF) Board signed in Geneva, Switzerland, an agreement for the implementation of a first collaborative project with Cuban agriculture.